Compare YDES & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | SLDP |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Electrical Products |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 463.5M |
| IPO Year | 2024 | 2021 |
| Metric | YDES | SLDP |
|---|---|---|
| Price | $2.99 | $2.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 29.5K | ★ 3.8M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,747,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $48.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $1.70 | $1.98 |
| 52 Week High | $25.00 | $8.86 |
| Indicator | YDES | SLDP |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 53.57 |
| Support Level | $2.88 | $2.21 |
| Resistance Level | $5.36 | $2.51 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 93.52 | 81.37 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.